3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

25,169

29,057

 

 

受取手形

137

90

 

 

売掛金

28,814

30,671

 

 

契約資産

702

821

 

 

有価証券

23,485

25,367

 

 

商品及び製品

13,706

12,463

 

 

仕掛品

199

790

 

 

原材料及び貯蔵品

11,074

12,268

 

 

その他

3,689

3,437

 

 

流動資産合計

106,980

114,969

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

39,422

41,745

 

 

 

 

減価償却累計額

30,845

30,703

 

 

 

 

建物及び構築物(純額)

8,577

11,042

 

 

 

土地

13,067

10,695

 

 

 

建設仮勘定

2,015

543

 

 

 

その他

17,342

20,569

 

 

 

 

減価償却累計額

13,932

14,758

 

 

 

 

その他(純額)

3,410

5,811

 

 

 

有形固定資産合計

27,069

28,093

 

 

無形固定資産

 

 

 

 

 

ソフトウエア

1,487

1,703

 

 

 

のれん

242

176

 

 

 

その他

164

89

 

 

 

無形固定資産合計

1,894

1,969

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

84,869

104,271

 

 

 

長期貸付金

5

4

 

 

 

長期前払費用

12,708

10,814

 

 

 

退職給付に係る資産

8,804

13,287

 

 

 

繰延税金資産

566

538

 

 

 

その他

1,178

1,157

 

 

 

貸倒引当金

18

18

 

 

 

投資その他の資産合計

108,115

130,055

 

 

固定資産合計

137,079

160,117

 

資産合計

244,059

275,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

4,602

6,661

 

 

短期借入金

1,280

1,250

 

 

未払法人税等

1,474

5,006

 

 

賞与引当金

2,183

2,298

 

 

役員賞与引当金

9

 

 

販売費引当金

129

129

 

 

契約負債

1,033

846

 

 

その他

5,866

5,494

 

 

流動負債合計

16,578

21,688

 

固定負債

 

 

 

 

繰延税金負債

16,481

21,029

 

 

役員退職慰労引当金

202

220

 

 

資産除去債務

149

130

 

 

その他

520

482

 

 

固定負債合計

17,354

21,862

 

負債合計

33,933

43,550

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

24,356

24,356

 

 

資本剰余金

24,226

24,243

 

 

利益剰余金

131,488

136,253

 

 

自己株式

14,520

15,513

 

 

株主資本合計

165,550

169,339

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

38,752

54,076

 

 

退職給付に係る調整累計額

4,701

6,730

 

 

その他の包括利益累計額合計

43,453

60,806

 

非支配株主持分

1,122

1,390

 

純資産合計

210,126

231,536

負債純資産合計

244,059

275,086

 

E00962 45470 キッセイ薬品工業株式会社 KISSEI PHARMACEUTICAL CO., LTD. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 45470 2026-05-11 45470 2025-04-01 2026-03-31 45470 2025-04-01 2026-03-31 jppfs_cor:CapitalStockMember 45470 2025-04-01 2026-03-31 jppfs_cor:CapitalSurplusMember 45470 2025-04-01 2026-03-31 jppfs_cor:NonControllingInterestsMember 45470 2025-04-01 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45470 2025-04-01 2026-03-31 jppfs_cor:RetainedEarningsMember 45470 2025-04-01 2026-03-31 jppfs_cor:ShareholdersEquityMember 45470 2025-04-01 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45470 2025-04-01 2026-03-31 jppfs_cor:TreasuryStockMember 45470 2025-04-01 2026-03-31 tse-acedjpfr-45470:InformationServiceReportableSegmentsMember 45470 2025-04-01 2026-03-31 tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember 45470 2025-04-01 2026-03-31 tse-acedjpfr-45470:TradingBusinessReportableSegmentMember 45470 2025-04-01 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45470 2025-04-01 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45470 2026-03-31 45470 2026-03-31 jppfs_cor:CapitalStockMember 45470 2026-03-31 jppfs_cor:CapitalSurplusMember 45470 2026-03-31 jppfs_cor:NonControllingInterestsMember 45470 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45470 2026-03-31 jppfs_cor:RetainedEarningsMember 45470 2026-03-31 jppfs_cor:ShareholdersEquityMember 45470 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45470 2026-03-31 jppfs_cor:TreasuryStockMember 45470 2026-03-31 tse-acedjpfr-45470:InformationServiceReportableSegmentsMember 45470 2026-03-31 tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember 45470 2026-03-31 tse-acedjpfr-45470:TradingBusinessReportableSegmentMember 45470 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45470 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45470 2024-04-01 2025-03-31 45470 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 45470 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 45470 2024-04-01 2025-03-31 jppfs_cor:NonControllingInterestsMember 45470 2024-04-01 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45470 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 45470 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 45470 2024-04-01 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45470 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 45470 2024-04-01 2025-03-31 tse-acedjpfr-45470:InformationServiceReportableSegmentsMember 45470 2024-04-01 2025-03-31 tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember 45470 2024-04-01 2025-03-31 tse-acedjpfr-45470:TradingBusinessReportableSegmentMember 45470 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45470 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45470 2025-03-31 45470 2025-03-31 jppfs_cor:CapitalStockMember 45470 2025-03-31 jppfs_cor:CapitalSurplusMember 45470 2025-03-31 jppfs_cor:NonControllingInterestsMember 45470 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45470 2025-03-31 jppfs_cor:RetainedEarningsMember 45470 2025-03-31 jppfs_cor:ShareholdersEquityMember 45470 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45470 2025-03-31 jppfs_cor:TreasuryStockMember 45470 2025-03-31 tse-acedjpfr-45470:InformationServiceReportableSegmentsMember 45470 2025-03-31 tse-acedjpfr-45470:PharmaceuticalProductsReportableSegmentsMember 45470 2025-03-31 tse-acedjpfr-45470:TradingBusinessReportableSegmentMember 45470 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45470 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45470 2024-03-31 45470 2024-03-31 jppfs_cor:CapitalStockMember 45470 2024-03-31 jppfs_cor:CapitalSurplusMember 45470 2024-03-31 jppfs_cor:NonControllingInterestsMember 45470 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45470 2024-03-31 jppfs_cor:RetainedEarningsMember 45470 2024-03-31 jppfs_cor:ShareholdersEquityMember 45470 2024-03-31 jppfs_cor:TreasuryStockMember 45470 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45470 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure